BriaCell Therapeutics Corp. (BCTX)
NASDAQ·Healthcare·Biotechnology
$4.05
+0.37%
Mkt Cap $7.08M
No analyst coverage available
We don't have analyst ratings or price target data for BriaCell Therapeutics Corp. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.